SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-24-001978
Filing Date
2024-11-14
Accepted
2024-11-14 16:05:42
Documents
66
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mrkr-20240930x10q.htm   iXBRL 10-Q 1295591
2 EX-31.1 mrkr-20240930xex31d1.htm EX-31.1 12001
3 EX-31.2 mrkr-20240930xex31d2.htm EX-31.2 11971
4 EX-32.1 mrkr-20240930xex32d1.htm EX-32.1 6154
5 EX-32.2 mrkr-20240930xex32d2.htm EX-32.2 6173
6 GRAPHIC mrkr-20240930x10q001.jpg GRAPHIC 9657
7 GRAPHIC mrkr-20240930x10q002.jpg GRAPHIC 46783
8 GRAPHIC mrkr-20240930x10q003.jpg GRAPHIC 30600
  Complete submission text file 0001410578-24-001978.txt   5599201

Data Files

Seq Description Document Type Size
9 EX-101.SCH mrkr-20240930.xsd EX-101.SCH 39805
10 EX-101.CAL mrkr-20240930_cal.xml EX-101.CAL 32306
11 EX-101.DEF mrkr-20240930_def.xml EX-101.DEF 168148
12 EX-101.LAB mrkr-20240930_lab.xml EX-101.LAB 312093
13 EX-101.PRE mrkr-20240930_pre.xml EX-101.PRE 259195
69 EXTRACTED XBRL INSTANCE DOCUMENT mrkr-20240930x10q_htm.xml XML 793674
Mailing Address 2450 HOLCOMBE BLVD SUITE BCM-A, MS: BCM251 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE BCM-A, MS: BCM251 HOUSTON TX 77021 (713) 400-6400
Marker Therapeutics, Inc. (Filer) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37939 | Film No.: 241461916
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)